Gufic Biosciences (NSE:GUFICBIO) Buildings And Improvements : ₹0 Mil (As of Dec. 2024)

View and export this data going back to 2004. Start your Free Trial

What is Gufic Biosciences Buildings And Improvements?

Gufic Biosciences's annual buildings and improvements increased from Mar. 2022 (₹555 Mil) to Mar. 2023 (₹914 Mil) but then declined from Mar. 2023 (₹914 Mil) to Mar. 2024 (₹779 Mil).

Gufic Biosciences Buildings And Improvements Historical Data

The historical data trend for Gufic Biosciences's Buildings And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gufic Biosciences Buildings And Improvements Chart

Gufic Biosciences Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Buildings And Improvements

Get a 7-Day Free Trial

339.71

358.05

555.10

913.93

779.45

Gufic Biosciences Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Buildings And Improvements	Get a 7-Day Free Trial															-	779.45	-	-	-

Gufic Biosciences Buildings And Improvements Calculation

Buildings are typically valued at the time of acquisition or construction. Broker and architect fees, permits, etc. can be covered within this category. Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.

Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized. Improvements are commonly recorded at acquisition cost. Building improvement examples include roofing, remodeling, replacements, etc.

Gufic Biosciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Gufic Biosciences Ltd (NSE:GUFICBIO) » Definitions » Buildings And Improvements

Traded in Other Exchanges

509079:India

Address

SM House, 11 Sahakar Road, 1st to 4th Floor, Vile Parle (East), Mumbai, MH, IND, 400 057

Website

https://www.gufic.com

Gufic Biosciences Ltd is engaged in the manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals, and related services. Geographically, it derives a majority of revenue from India. Its product portfolio includes Criticare; Criticare Life; Ferticare; Spark; Herbal and other products. The company's lyophilized product includes antibiotics, anti-fungal, cardiac, infertility, anti-viral and a proton-pump inhibitor. It derives maximum revenue from India.

Gufic Biosciences Headlines

No Headlines